Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company SNP Bio Inc.
DescriptionGenetic test based on 33 cancer risk-associated single nucleotide polymorphisms (SNPs)
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics: Biomarkers and companion diagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsDetect prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today